PGGM Investments reduced its stake in shares of Aetna Inc. (NYSE:AET) by 6.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 698,394 shares of the company’s stock after selling 47,510 shares during the period. PGGM Investments owned 0.21% of Aetna worth $106,037,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of the stock. FTB Advisors Inc. boosted its position in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares in the last quarter. Signature Estate & Investment Advisors LLC acquired a new position in shares of Aetna during the first quarter valued at approximately $133,000. Liberty Capital Management Inc. boosted its position in shares of Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares in the last quarter. Horan Capital Management acquired a new position in shares of Aetna during the first quarter valued at approximately $157,000. Finally, Guardian Life Insurance Co. of America boosted its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares in the last quarter. 91.69% of the stock is owned by institutional investors.
Shares of Aetna Inc. (AET) traded down 0.87% during trading on Friday, hitting $154.45. 1,781,161 shares of the company traded hands. Aetna Inc. has a one year low of $104.59 and a one year high of $161.69. The stock has a market cap of $51.29 billion, a price-to-earnings ratio of 34.28 and a beta of 0.54. The firm has a 50 day moving average price of $154.81 and a 200-day moving average price of $140.38.
Aetna (NYSE:AET) last announced its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same period last year, the company posted $2.21 earnings per share. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. Analysts predict that Aetna Inc. will post $9.55 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This article was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.com-unik.info/2017/08/19/aetna-inc-aet-position-cut-by-pggm-investments-updated-updated.html.
Several brokerages have commented on AET. Deutsche Bank AG raised their price target on shares of Aetna from $144.00 to $157.00 and gave the company a “hold” rating in a research report on Thursday, July 13th. Credit Suisse Group reissued a “buy” rating and issued a $155.00 price target on shares of Aetna in a research report on Wednesday, May 17th. Cowen and Company set a $170.00 price target on shares of Aetna and gave the company a “buy” rating in a research report on Saturday, May 27th. Jefferies Group LLC reissued a “hold” rating and issued a $163.00 price target (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $175.00 price objective (up from $150.00) on shares of Aetna in a research report on Wednesday, August 9th. Seven research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $157.99.
In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the firm’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.